The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 3, 2023 | Requadt Scott | Insider | Tax withholding(F) | 12K | $3.08 | $36K |
| Jul 3, 2023 | Fenton Mary Kay | Chief Financial Officer | Tax withholding(F) | 13K | $3.08 | $40K |
| Jun 14, 2023 | Ildstad Suzanne | Director | Sell(S) | 13K | $2.49 | $32K |
| Jun 13, 2023 | Agarwala Sandip | Director | Grant(A) | 21K | — | $0 |
| Jun 13, 2023 | Ildstad Suzanne | Director | Sell(S) | 14K | $2.56 | $36K |
| Jun 13, 2023 | Ildstad Suzanne | Director | Grant(A) | 21K | — | $0 |
| Jun 13, 2023 | Mackay Geoffrey | Director | Grant(A) | 21K | — | $0 |
| Jun 13, 2023 | McDade Mark | Director | Grant(A) | 21K | — | $0 |
| Jun 13, 2023 | Nader Francois | Director | Grant(A) | 41K | — | $0 |
| Jun 13, 2023 | Shah Gaurav | Director | Grant(A) | 21K | — | $0 |
| Jun 13, 2023 | Smith Karen L. | Director | Grant(A) | 21K | — | $0 |
| Jun 13, 2023 | Srivastava Sapna | Director | Grant(A) | 21K | — | $0 |
| Jun 12, 2023 | Ildstad Suzanne | Director | Sell(S) | 17K | $2.59 | $44K |
| Jun 9, 2023 | Ildstad Suzanne | Director | Sell(S) | 25K | $2.46 | $63K |
| Jun 8, 2023 | Ildstad Suzanne | Director | Sell(S) | 41K | $2.48 | $101K |
| Jun 7, 2023 | Ildstad Suzanne | Director | Sell(S) | 75K | $2.39 | $179K |
| Jun 6, 2023 | Ildstad Suzanne | Director | Sell(S) | 26K | $2.53 | $65K |
| Jun 5, 2023 | Ildstad Suzanne | Director | Sell(S) | 8K | $2.52 | $20K |
| Jun 2, 2023 | Ildstad Suzanne | Director | Sell(S) | 16K | $2.50 | $40K |
| Jun 1, 2023 | Ildstad Suzanne | Director | Sell(S) | 16K | $2.56 | $40K |
| Apr 21, 2023 | Ildstad Suzanne | Director | Sell(S) | 15K | $2.35 | $35K |
| Apr 20, 2023 | Ildstad Suzanne | Director | Sell(S) | 47K | $2.33 | $109K |
| Apr 19, 2023 | Ildstad Suzanne | Director | Sell(S) | 22K | $2.16 | $47K |
| Apr 18, 2023 | Ildstad Suzanne | Director | Sell(S) | 49K | $2.15 | $106K |
| Apr 17, 2023 | Ildstad Suzanne | Director | Sell(S) | 100K | $2.14 | $214K |
| Mar 17, 2023 | Ildstad Suzanne | Director | Sell(S) | 10K | $2.06 | $21K |
| Mar 3, 2023 | Ildstad Suzanne | Director | Sell(S) | 7K | $2.06 | $14K |
| Mar 1, 2023 | Ildstad Suzanne | Director | Sell(S) | 29 | $2.05 | $59 |
| Feb 21, 2023 | Ildstad Suzanne | Director | Sell(S) | 4K | $2.05 | $7K |
| Feb 17, 2023 | Ildstad Suzanne | Director | Sell(S) | 4K | $2.05 | $7K |
| Feb 16, 2023 | Ildstad Suzanne | Director | Sell(S) | 3K | $2.06 | $6K |
| Feb 1, 2023 | Fenton Mary Kay | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| Feb 1, 2023 | Fenton Mary Kay | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| Feb 1, 2023 | Krieger Nancy | Chief Medical Officer | Grant(A) | 120K | — | $0 |
| Feb 1, 2023 | Krieger Nancy | Chief Medical Officer | Grant(A) | 120K | — | $0 |
| Feb 1, 2023 | Requadt Scott | Chief Executive Officer, Director | Grant(A) | 320K | — | $0 |
| Feb 1, 2023 | Requadt Scott | Chief Executive Officer, Director | Grant(A) | 320K | — | $0 |
| Feb 1, 2023 | Zdanowski Michael | Chief Technology Officer | Grant(A) | 150K | — | $0 |
| Feb 1, 2023 | Zdanowski Michael | Chief Technology Officer | Grant(A) | 150K | — | $0 |
| Dec 30, 2022 | Requadt Scott | Chief Executive Officer, Director | Grant(A) | 4 | $0.87 | $3 |
| Sep 10, 2022 | Fenton Mary Kay | Chief Financial Officer | Grant(A) | 80K | — | $0 |
| Sep 10, 2022 | Requadt Scott | Chief Executive Officer, Director | Grant(A) | 80K | — | $0 |
| Sep 10, 2022 | Krieger Nancy | Chief Medical Officer | Grant(A) | 80K | — | $0 |
| Sep 10, 2022 | Zdanowski Michael | Chief Technology Officer | Grant(A) | 120K | — | $0 |
| Aug 22, 2022 | Ildstad Suzanne | Chief Scientific Officer | Sell(S) | 525K | $2.80 | $1.5M |
| Jul 29, 2022 | Requadt Scott | Chief Executive Officer, Director | Buy(P) | 39K | $4.25 | $167K |
| Jul 28, 2022 | Requadt Scott | Chief Executive Officer, Director | Buy(P) | 3K | $4.25 | $13K |
| Jul 26, 2022 | Requadt Scott | Chief Executive Officer, Director | Buy(P) | 6K | $4.24 | $23K |
| Jul 25, 2022 | Nader Francois | Director | Other(J) | 139K | — | $0 |
| Jul 25, 2022 | Nader Francois | Director | Other(J) | 139K | — | $0 |
| Jul 22, 2022 | Requadt Scott | Chief Executive Officer, Director | Buy(P) | 9K | $3.75 | $35K |
| Jul 21, 2022 | Nader Francois | Director | Other(J) | 248K | — | $0 |
| Jul 21, 2022 | Nader Francois | Director | Other(J) | 248K | — | $0 |
| Jul 21, 2022 | Nader Francois | Director | Buy(P) | 37K | $3.72 | $136K |
| Jul 20, 2022 | Nader Francois | Director | Buy(P) | 52K | $3.62 | $188K |
| Jul 19, 2022 | Nader Francois | Director | Buy(P) | 50K | $3.52 | $176K |
| Jun 9, 2022 | Srivastava Sapna | Director | Grant(A) | 15K | — | $0 |
| Jun 9, 2022 | Agarwala Sandip | Director, 10% Owner | Grant(A) | 15K | — | $0 |
| Jun 9, 2022 | Nader Francois | Director | Grant(A) | 15K | — | $0 |
| Jun 9, 2022 | Mackay Geoffrey | Director | Grant(A) | 15K | — | $0 |
| Jun 9, 2022 | Smith Karen L. | Director | Grant(A) | 15K | — | $0 |
| Jun 9, 2022 | Shah Gaurav | Director | Grant(A) | 15K | — | $0 |
| Jun 9, 2022 | McDade Mark | Director | Grant(A) | 15K | — | $0 |
| May 16, 2022 | Smith Karen L. | Director | Grant(A) | 29K | — | $0 |
| Feb 1, 2022 | Zdanowski Michael | Chief Technology Officer | Grant(A) | 200K | — | $0 |
| Feb 1, 2022 | Fenton Mary Kay | Chief Financial Officer | Grant(A) | 200K | — | $0 |
| Feb 1, 2022 | Requadt Scott | Chief Executive Officer, Director | Grant(A) | 500K | — | $0 |
| Feb 1, 2022 | Krieger Nancy | Chief Medical Officer | Grant(A) | 190K | — | $0 |
| Feb 1, 2022 | Ildstad Suzanne | Chief Scientific Officer | Grant(A) | 150K | — | $0 |
| Dec 31, 2021 | Zdanowski Michael | Chief Technology Officer | Grant(A) | 1K | $13.00 | $19K |
| Dec 31, 2021 | Fenton Mary Kay | Chief Financial Officer | Grant(A) | 1K | $13.00 | $13K |
| Dec 31, 2021 | Requadt Scott | Chief Executive Officer, Director | Grant(A) | 1K | $13.00 | $19K |
| Dec 15, 2021 | Nader Francois | Director | Gift(G) | 60K | — | $0 |
| Nov 17, 2021 | Ildstad Suzanne | Chief Scientific Officer | Gift(G) | 1.2M | — | $0 |
| Nov 17, 2021 | Ildstad Suzanne | Chief Scientific Officer | Gift(G) | 1.2M | — | $0 |
| May 11, 2021 | Blackstone Holdings II L.P. | 10% Owner | Conversion(C) | 717K | — | — |
| May 11, 2021 | Blackstone Holdings II L.P. | 10% Owner | Conversion(C) | 677K | — | — |
| May 11, 2021 | Blackstone Holdings II L.P. | 10% Owner | Conversion(C) | 367K | — | — |
| May 11, 2021 | Blackstone Holdings II L.P. | 10% Owner | Conversion(C) | 563K | — | — |
| May 11, 2021 | Blackstone Holdings II L.P. | 10% Owner | Conversion(C) | 279K | — | — |
| May 11, 2021 | Blackstone Holdings II L.P. | 10% Owner | Conversion(C) | 697K | — | — |
| May 11, 2021 | Longitude Capital Partners III, LLC | 10% Owner | Conversion(C) | 3.0M | — | — |
| May 11, 2021 | Longitude Capital Partners III, LLC | 10% Owner | Buy(P) | 235K | $17.00 | $4.0M |
| May 11, 2021 | Longitude Capital Partners III, LLC | 10% Owner | Conversion(C) | 406K | — | $0 |
| May 11, 2021 | Longitude Capital Partners III, LLC | 10% Owner | Conversion(C) | 1.3M | — | $0 |
| May 11, 2021 | Longitude Capital Partners III, LLC | 10% Owner | Conversion(C) | 1.3M | — | $0 |
| May 11, 2021 | Agarwala Sandip | Director, 10% Owner | Conversion(C) | 3.0M | — | — |
| May 11, 2021 | Agarwala Sandip | Director, 10% Owner | Buy(P) | 235K | $17.00 | $4.0M |
| May 11, 2021 | Agarwala Sandip | Director, 10% Owner | Conversion(C) | 406K | — | $0 |
| May 11, 2021 | Agarwala Sandip | Director, 10% Owner | Conversion(C) | 1.3M | — | $0 |
| May 11, 2021 | Agarwala Sandip | Director, 10% Owner | Conversion(C) | 1.3M | — | $0 |
| May 11, 2021 | Clarus Defined Exit I, L.P. | 10% Owner | Conversion(C) | 130K | — | — |
| May 11, 2021 | Clarus Defined Exit I, L.P. | 10% Owner | Conversion(C) | 52K | — | — |
| May 11, 2021 | Clarus Defined Exit I, L.P. | 10% Owner | Conversion(C) | 105K | — | — |
| May 11, 2021 | Clarus Defined Exit I, L.P. | 10% Owner | Conversion(C) | 69K | — | — |
| May 11, 2021 | Clarus Defined Exit I, L.P. | 10% Owner | Conversion(C) | 126K | — | — |
| May 11, 2021 | Clarus Defined Exit I, L.P. | 10% Owner | Conversion(C) | 25K | — | — |
| May 11, 2021 | Clarus Defined Exit I, L.P. | 10% Owner | Buy(P) | 16K | $17.00 | $271K |
| May 11, 2021 | Clarus Defined Exit I, L.P. | 10% Owner | Buy(P) | 4K | $17.00 | $61K |
| May 11, 2021 | Clarus Defined Exit I, L.P. | 10% Owner | Buy(P) | 1K | $17.00 | $25K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).